Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion type Assertion NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_head.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion description "[These analyses revealed that 5 genes, i.e., AMOG (ATP1B2, 17p13.1), APOD (3q26.2-qter), DMXL1 (5q23.1) DRR1 (TU3A, 3p14.2) and PSD3 (KIAA09428/HCA67/EFA6R, 8p22), were expressed at significantly lower levels in secondary glioblastomas as compared to diffuse astrocytomas of WHO grade II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_provenance.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion evidence source_evidence_literature NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_provenance.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion SIO_000772 16865689 NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_provenance.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion wasDerivedFrom befree-20150227 NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_provenance.
- NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_assertion wasGeneratedBy ECO_0000203 NP924440.RAj5f_SkPiAY-cLQZprLp-yGMyUjnsCOOpWdueIBe2WPE130_provenance.